OneSource Specialty Pharma Limited, has successfully received the renewal of the European Union Good Manufacturing Practices (EU-GMP) certification for its flagship Unit II manufacturing facility, located in Bengaluru, following an inspection conducted by a European regulatory authority.
Unit II is is a flagship integrated biologics drug-substance and drug-product manufacturing site with capabilities in drug-device combinations and sterile injectable products.
Shares of Onesource Specialty Pharma Limited was last trading in BSE at Rs. 1540.35 as compared to the previous close of Rs. 1505.95. The total number of shares traded during the day was 6428 in over 862 trades.
The stock hit an intraday high of Rs. 1549.40 and intraday low of 1489.45. The net turnover during the day was Rs. 9742887.00.